Full Text View
Tabular View
No Study Results Posted
Related Studies
Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl (FTN)
This study has been completed.
First Received: January 14, 2008   Last Updated: March 11, 2008   History of Changes
Sponsor: Federal University of São Paulo
Information provided by: Federal University of São Paulo
ClinicalTrials.gov Identifier: NCT00635986
  Purpose

CONTEXT AND OBJECTIVE: Controversies exist regarding the site of action of Fentanyl after epidural injection. The objective of this investigation was to compare the analgesic effect of epidural and intravenous Fentanyl for lower limb orthopedic surgeries.

DESIGN AND SETTING: A randomized and double-blind study was performed in Hospital São Paulo.

METHODS: 29 patients were divided into two groups. During the postoperative period, in the presence of pain, group 1 (n = 14) patients received 5 mL of a 100 mcg Fentanyl solution in saline without preservative by the epidural route and 2 mL saline intravenously. Group 2 (n = 15) patients received 5 mL saline by the epidural route and 2 mL (100 mcg) Fentanyl intravenously. Analgesic supplementation consisted of 40 mg intravenous Tenoxicam and 5 mL epidural 0.25% bupivacaine (if pain relief was not achieved with Tenoxicam). Pain intensity was evaluated by numerical scale and plasma concentrations of Fentanyl were measured simultaneously.


Condition Intervention
Fentanyl Analgesia
Drug: Fentanyl

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Pharmacodynamics Study
Official Title: Analgesic Effect and Plasma Concentration of Epidural Versus Intravenous Fentanyl

Resource links provided by NLM:


Further study details as provided by Federal University of São Paulo:

Primary Outcome Measures:
  • Pain relief [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • fentanyl plasma concentration measure in different times [ Time Frame: 1year ] [ Designated as safety issue: Yes ]

Enrollment: 30
Study Start Date: May 2004
Study Completion Date: November 2006
Primary Completion Date: June 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
group 1 (n = 14) patients received 5 mL of a 100 mcg Fentanyl solution in saline without preservative by the epidural route and 2 mL saline intravenously. Group 2 (n = 15) patients received 5 mL saline by the epidural route and 2 mL (100 mcg) Fentanyl intravenously
Drug: Fentanyl
100 mcg Fentanyl intravenous or epidural route

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Both genders ranging in age from 18 to 65 years, American Society of Anesthesiologists (ASA) Physical Status 1 or 2, scheduled for orthopedic bone surgery of the lower limbs

Exclusion Criteria:

  • Patients with infection in the puncture area and coagulation disorders, pregnant patients, and patients using opioids
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00635986

Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Chair: Adriana M Issy, PhD Federal University of São Paulo
  More Information

No publications provided

Responsible Party: Universidade Federal de São Paulo ( Adriana Machado Issy/ Professor )
Study ID Numbers: Fentanyl, No grant
Study First Received: January 14, 2008
Last Updated: March 11, 2008
ClinicalTrials.gov Identifier: NCT00635986     History of Changes
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by Federal University of São Paulo:
Analgesia
Fentanyl
Orthopedic
Mechanism of action
Surgery

Additional relevant MeSH terms:
Anesthetics, Intravenous
Fentanyl
Physiological Effects of Drugs
Anesthetics
Central Nervous System Depressants
Narcotics
Pharmacologic Actions
Adjuvants, Anesthesia
Sensory System Agents
Anesthetics, General
Therapeutic Uses
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on November 27, 2009